Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

OBJECTIVE: Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of disease relapse after discontinuation of TNF inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, Schilder, Annemarie M., Visser, Henk, Sasso, Eric H., Chernoff, David, Lems, Willem F., van Schaardenburg, Dirk-Jan, Landewe, Robert, Bernelot Moens, Hein J., Radstake, Timothy R. D. J., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965880/
https://www.ncbi.nlm.nih.gov/pubmed/29791439
http://dx.doi.org/10.1371/journal.pone.0192425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965880/
https://www.ncbi.nlm.nih.gov/pubmed/29791439
http://dx.doi.org/10.1371/journal.pone.0192425

Ejemplares similares